Paper42401883
Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study.
Huang Y and 13 others. Cardiovasc Diabetol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study. Papers, record 42401883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42401883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study.
- PubMed
- Publication types
- Comparative Study, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Glucose | Major topic |
| Cardiovascular Diseases | Major topic |
| Insulin Resistance | Major topic |
| Metabolic Syndrome | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Biomarkers | |
| Cardiometabolic Risk Factors | |
| China | |
| Inflammation Mediators | |
| Nutrition Surveys | |
| Predictive Value of Tests | |
| Prognosis | |
| Risk Assessment | |
| Risk Factors | |
| Time Factors | |
| Triglycerides | |
| UK Biobank | |
| United States |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82403381 | National Natural Science Foundation of China | PubMed | ||
| 82030099 | National Natural Science Foundation of China | PubMed | ||
| 24YF2722700 | Sailing Program of Shanghai Rising-Star Program | PubMed | ||
| 2022YFD2101500 | National Key R&D Program of China | PubMed | ||
| 2026ZB0556800 | Noncommunicable Chronic Diseases-National Science and Technology Major Project | PubMed | ||
| YG2025LC14 | Medical-Engineering Cross Foundation of Shanghai Jiao Tong University | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41943105 | The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41943105 | PubMed |
| 2 | 35833264 | The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/35833264 | PubMed |
| 3 | 15307867 | Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. | Am J Gastroenterol | 2004 | https://conductscience.org/library/papers/15307867 | PubMed |
| 4 | 41607621 | Metabolic dysfunction-associated steatotic liver disease and heart failure with preserved ejection fraction: A state-of-the-art review. | World J Cardiol | 2026 | https://conductscience.org/library/papers/41607621 | PubMed |
| 5 | 38310873 | Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective. | Diabetes Metab J | 2024 | https://conductscience.org/library/papers/38310873 | PubMed |
| 6 | 38664793 | Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38664793 | PubMed |
| 7 | 38409325 | A homoeostatic switch causing glycerol-3-phosphate and phosphoethanolamine accumulation triggers senescence by rewiring lipid metabolism. | Nat Metab | 2024 | https://conductscience.org/library/papers/38409325 | PubMed |
| 8 | 30962418 | FASN activity is important for the initial stages of the induction of senescence. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30962418 | PubMed |
| 9 | 38902748 | Is systemic inflammation a missing link between cardiometabolic index with mortality? Evidence from a large population-based study. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38902748 | PubMed |
| 10 | 40158078 | Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40158078 | PubMed |
| 11 | 30828530 | Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/30828530 | PubMed |
| 12 | 39014415 | Association of atherogenic index of plasma with cardiovascular disease mortality and all-cause mortality in the general US adult population: results from NHANES 2005-2018. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/39014415 | PubMed |
| 13 | 40281579 | Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/40281579 | PubMed |
| 14 | 20056946 | The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. | Circ Res | 2010 | https://conductscience.org/library/papers/20056946 | PubMed |
| 15 | 41327275 | METS-IR predicts new-onset stroke in older adults with stages 0-3 cardiovascular-kidney-metabolic syndrome: a prospective, multicohort, clinical study with statistical and machine learning. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/41327275 | PubMed |
| 16 | 35798021 | The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35798021 | PubMed |
| 17 | 38987779 | Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38987779 | PubMed |
| 18 | 36599349 | Hallmarks of aging: An expanding universe. | Cell | 2023 | https://conductscience.org/library/papers/36599349 | PubMed |
| 19 | 32321858 | NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. | Gut | 2020 | https://conductscience.org/library/papers/32321858 | PubMed |
| 20 | 35778734 | TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. | Cardiovasc Diabetol | 2022 | https://conductscience.org/library/papers/35778734 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42658392 | From liver to cardiovascular system: the MASLD-ASCVD continuum. | Intern Emerg Med | 2026 | https://conductscience.org/library/papers/42658392 | PubMed |
| 42638798 | Cumulative lipid-inflammatory indices and the risk of cardiometabolic multimorbidity: a prospective cohort study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42638798 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42401883
GET https://conductscience.org/api/papers/v1/42401883/references?page=2